Small Times reports on a meeting held in Oregon among a wide variety of nanotechnology-based business participants, at which many commercialization challenges were discussed. One was difficulties encountered with the U.S. Patent office: Start-ups expressed frustration with the U.S. Patent and Trademark Office (USPTO). Long waits for patent ...

Foresight members and others would like to find ways to use nanotechnology to help those who need help the most. It’s a challenge, as described more generally by Nancy Birdsall, Dani Rodrik, and Arvind Subramanian, writing in Foreign Affairs. They suggest a solution, which ought to work for nanotech as well as medical [...]

Darrell Dvorak at MidwestBusiness.com points out that there’s often some expertise missing from discussions on nanotech risk: Because nanotech operates at the molecular level, there has been much speculation about new, unknown risks of nano products and processes… An encouraging development for a fact-based approach is that ...